Xizang Weixinkang Pharmaceutical (603676)
Tibet Weixinkang Medicine Co., Ltd. engages in the research and development, production, and sale of chemical drugs and their bulk drugs in China. It offers API...
- Open
- 9.58
- High
- 9.58
- Low
- 9.19
- Prev. Close
- 9.62
- Volume
- 38.62K
- Turnover
- 36.13M
- Avg Price
- 9.36
- Bid/Ask Ratio
- --
- Amplitude
- 4.05%
- 52wk High
- 13.17
- Volume Ratio
- 1.18
- Turnover Ratio
- 0.89%
News
- Zhitong · Oct 29, 2025 at 09:22 AM
Xizang Weixinkang Pharmaceutical released its performance for the first three quarters, with a net profit attributable to the parent company of 219 million yuan, a year-on-year decrease of 9.9%
- Zhitong · Aug 27, 2025 at 04:31 AM
Xizang Weixinkang Pharmaceutical: Net profit of 183 million yuan in the first half of 2025, a year-on-year increase of 11.82%
- Zhitong · Jul 7, 2025 at 08:48 PM
Pharmaceutical stocks continue to be strong, FUSHILAI hits the 20% limit up, Tuoxin Pharmaceutical and Cosunter rise over 10%, Xizang Weixinkang Pharmaceutical, MEDISAN and several other stocks hit the limit up
- Zhitong · Jun 30, 2025 at 06:38 AM
Xizang Weixinkang Pharmaceutical: Received government subsidies related to revenue amounting to 34.3437 million yuan
- Zhitong · Jun 24, 2025 at 03:38 AM
Xizang Weixinkang Pharmaceutical: Cooperative product injectable multivitamins (12) passed the consistency evaluation of generic drugs
- Zhitong · May 9, 2025 at 02:57 AM
Xizang Weixinkang Pharmaceutical's subsidiary withdraws the registration application for Pediatric Compound Amino Acid Injection (20AA)
